← Back to Screener
Adagene Inc. American Depositary Shares (ADAG)
Price$3.89
Favorite Metrics
Price vs S&P 500 (26W)94.84%
Price vs S&P 500 (4W)-0.13%
Market Capitalization$188.12M
All Metrics
Book Value / Share (Quarterly)$0.88
P/TBV (Annual)0.76x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)-6.18%
Cash Flow / Share (Quarterly)$-0.26
Price vs S&P 500 (YTD)105.91%
Net Profit Margin (TTM)-53.87%
EPS (TTM)$-0.30
10-Day Avg Trading Volume0.45M
EPS Excl Extra (TTM)$-0.30
Revenue Growth (5Y)61.42%
EPS (Annual)$-0.30
ROI (Annual)-30.35%
Net Profit Margin (5Y Avg)-6860.31%
Cash / Share (Quarterly)$1.26
Revenue Growth QoQ (YoY)7333.04%
ROA (Last FY)-22.50%
Revenue Growth TTM (YoY)7333.04%
EBITD / Share (TTM)$-0.35
ROE (5Y Avg)-53.98%
Operating Margin (TTM)-74.96%
Cash Flow / Share (Annual)$-0.26
P/B Ratio3.62x
P/B Ratio (Quarterly)1.65x
Net Income / Employee (Annual)$-0
EV / Revenue (TTM)15.61x
Net Interest Coverage (TTM)-79.31x
ROA (TTM)-24.33%
EPS Incl Extra (Annual)$-0.30
Current Ratio (Annual)3.07x
Quick Ratio (Quarterly)3.06x
3-Month Avg Trading Volume0.20M
52-Week Price Return151.27%
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$1.92
P/S Ratio (Annual)24.52x
Asset Turnover (Annual)0.10x
52-Week High$4.75
Operating Margin (5Y Avg)-7372.27%
EPS Excl Extra (Annual)$-0.30
CapEx CAGR (5Y)-55.15%
26-Week Price Return103.59%
Quick Ratio (Annual)3.06x
13-Week Price Return120.56%
Total Debt / Equity (Annual)0.12x
Current Ratio (Quarterly)3.07x
Enterprise Value$119.715
Revenue / Share Growth (5Y)52.04%
Asset Turnover (TTM)0.10x
Revenue / Employee (Annual)$0
Pretax Margin (Annual)-233.44%
Cash / Share (Annual)$1.26
3-Month Return Std Dev122.08%
Net Income / Employee (TTM)$-0
ROE (Last FY)-33.93%
EPS Basic Excl Extra (Annual)$-0.30
Receivables Turnover (TTM)6.20x
Total Debt / Equity (Quarterly)0.12x
EPS Incl Extra (TTM)$-0.30
Receivables Turnover (Annual)6.19x
ROI (TTM)-34.34%
P/S Ratio (TTM)24.52x
Pretax Margin (5Y Avg)-6858.29%
Revenue / Share (Annual)$0.13
Tangible BV / Share (Annual)$1.92
Price vs S&P 500 (52W)116.17%
Year-to-Date Return110.05%
5-Day Price Return3.39%
EPS Normalized (Annual)$-0.30
ROA (5Y Avg)-33.48%
Net Profit Margin (Annual)-229.56%
Month-to-Date Return1.28%
EBITD / Share (Annual)$-0.35
Operating Margin (Annual)-279.48%
LT Debt / Equity (Annual)0.02x
ROI (5Y Avg)-43.23%
LT Debt / Equity (Quarterly)0.02x
EPS Basic Excl Extra (TTM)$-0.30
P/TBV (Quarterly)0.76x
P/B Ratio (Annual)1.65x
Pretax Margin (TTM)-57.76%
Book Value / Share (Annual)$0.88
Price vs S&P 500 (13W)117.69%
Beta0.65x
Revenue / Share (TTM)$0.13
ROE (TTM)-39.21%
52-Week Low$1.30
Industry Peers — Pharmaceuticals(308)
| Symbol | P/S Ratio (TTM) | Revenue Growth TTM (YoY) | Gross Margin (TTM) | EPS Growth (5Y) | Price |
|---|---|---|---|---|---|
ADAGAdagene Inc. American Depositary Shares | 24.52x | 7333.04% | — | — | $3.89 |
LLYEli Lilly & Co. | 13.45x | 44.70% | 83.04% | 27.59% | $919.90 |
JNJJohnson & Johnson | 5.82x | 7.87% | 67.95% | 14.90% | $230.69 |
ABBVABBVIE INC. | 5.97x | 8.57% | 71.62% | -2.88% | $203.71 |
MRKMerck & Co., Inc. | 4.51x | 1.31% | 78.55% | 21.23% | $117.10 |
AZNAstraZeneca PLC | 5.39x | 8.63% | 81.31% | 21.88% | $200.69 |
NVSNovartis AG | 4.87x | 8.91% | 75.82% | 15.26% | $150.99 |
NVONovo-Nordisk A/S | 3.74x | 6.43% | 80.98% | 20.66% | $40.46 |
ABTAbbott Laboratories | 3.71x | 6.59% | 56.50% | 8.20% | $96.00 |
PFEPfizer Inc. | 2.50x | -1.64% | 75.81% | -3.51% | $27.52 |
BMYBristol-Myers Squibb Co. | 2.52x | -0.22% | 72.63% | — | $59.13 |
About
Adagene is a clinical-stage biopharmaceutical company developing monoclonal antibody immunotherapies for cancer treatment. The company's proprietary platform generates therapeutic antibody candidates with enhanced functional epitopes and species cross-reactivity, enabling a differentiated pipeline of cancer immunotherapy programs.